Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,784 total articles
UTI surged into the summer, peaked at $51.34, then reversed violently to the low-$20s. The pullback looks driven by a mix of profit taking, stretched valuation and heavy short activity. Technicals are deeply oversold; fundamentals remain mixed - solid revenue growth but negative free cash flow and a high P/E. This trade targets a tactical mean-reve…
Uniti Group (UNIT) has shifted from a financing story to an earnings growth story as its fiber buildout and Kinetic subscriber expansion are starting to convert capital spending into durable revenue and EBITDA. The balance sheet still matters, but recent securitizations and a sizable senior note issuance have extended liquidity while bookings and f…
Methanex is intentionally shrinking unreliable capacity and prioritizing cash flow reliability. With production discipline, a cleaner balance sheet and rising methanol spot prices, the stock can earn a multiple premium despite a rich headline valuation. This trade targets that reliability premium with a defined entry, stop and target over a 180-tra…
Moderna ($150.81) is expensive on headline multiples - market cap ~$60.2B and price-to-sales ~27 - yet the stock carries asymmetric upside from an expanding mRNA franchise (recent FDA flu approval and oncology momentum). This trade idea takes a disciplined long stance sized for high volatility: entry $150.81, stop $136.00, target $190.00, horizon 1…
MSA has favorable fundamentals and cash generation driven by industrial PPE, but fire-service equipment and gas-detection face mixed demand. Valuation is full but reasonable given returns and free cash flow. This trade idea buys a measured long with tight risk control and a clear re-check plan.
Summit Therapeutics (SMMT) is trading like a growth oncology story priced for approval. With an FDA decision on ivonescimab expected 11/14/2026, the stock faces a binary outcome: a re-rating on approval or a sharp derating on rejection or label limitations. This trade idea outlines a tactical short designed to capture the asymmetric downside into t…
REMX gives direct, diversified exposure to the rare-earth and strategic-metals complex at a time when government-backed deals and industrial demand are tightening supply. With a market cap near $2.24B, a recent sector-reshaping acquisition and rising short interest, REMX offers a tactical long opportunity for investors willing to accept commodity-c…
Nvidia's scale in data-center GPUs and networking means each incremental gigawatt of deployed accelerated compute translates into outsized revenue opportunity. At today's $224.60 stock price and a $5.52 trillion market cap, the company already prices in a lot of growth — but a repeatable cadence of GW additions at roughly $40B in economic value per…
Turkcell (TKC) trades at just $5.08 with a market cap near $4.45B, a P/E under 10 and a 3.1% yield. The business is cash-generative and diversified across core mobile, international operations and fast-growing Techfin payments. We see a favorable risk-reward over the next 180 trading days as operational improvements and monetization of digital serv…
SoFi has reported solid Q2 operational progress — 40% adjusted net revenue growth, a 44% lift in adjusted EBITDA and 15.8 million members after a 1.1M add — yet the share price is essentially flat. With valuation nearer-term improved and several visible catalysts ahead, I’m adding to a long position at current prices with a disciplined stop and a c…
PayPal rejected a $60.50 takeover offer and the stock now trades around $54.66. Valuation metrics look reasonable - P/E ~9.5, EV/EBITDA ~7.2 - while the business still generates substantial free cash flow and TPV growth. This trade idea targets a rebound if either renewed deal chatter appears or execution on Venmo, BNPL and margin recovery accelera…
AST SpaceMobile plunged on macro concerns but still trades on lofty multiples despite early revenue. With $2.7B in cash, carrier partnerships, and growing short interest, the risk/reward looks attractive for a mid-term swing. This trade lays out entry, stop, targets and the scenario work that would change the view.
British American Tobacco (BTI) offers a 5.7% yield, a market cap near $122B, and a PE of ~14.3. For income-focused investors willing to stomach regulatory and secular headwinds, BTI is an actionable long-term trade: enter at current levels, target a move back toward the 52-week highs, and protect principal with a defined stop.
Jones Lang LaSalle (JLL) has the balance sheet, cash flow and premium services mix to benefit from a gradual commercial real estate recovery. At roughly $350 today, the stock prices in a partial rebound but leaves upside if leasing, transaction activity and LaSalle's investment management rebound. We recommend a tactical long with a $420 target and…
3M has shown measurable margin improvement driven by restructuring and productivity initiatives. With adjusted operating margin near 25% and guidance for continued expansion, the setup favors a tactical long that pairs earnings resiliency with improving cash generation. The trade balances upside from multiple re-rating and margin gains against elev…
Netflix is moving beyond pure subscriber growth into a multi-pronged monetization cycle — ad tiers, live sports, gaming and licensing — that should drive meaningful revenue and margin expansion over the next 6-12 months. The stock trades at $82.72 with a market cap near $344B and a 2026 P/E around 25x; I see asymmetric upside to $110 in a 180-tradi…
Howmet (HWM) has been marked down on headlines tying a turbine issue at a major space/rocket player to the broader aero supply chain. Fundamentals remain intact: $100.9B market cap, strong free cash flow, and durable engineered-products franchises. This trade idea lays out an entry at $253.73, a stop at $238.00, and a primary target of $305.00 over…
Chevron's recent commitments — most notably a $7 billion Venezuela expansion announced 09/02/2026 and growing production through strategic partnerships such as Hess — materially strengthen its production profile and cash-generation outlook. At roughly $212/share and a market cap near $418B, Chevron offers a mix of income, capital return optionality…
Sterling Infrastructure's e-infrastructure boom and recent acquisitions make its growth story credible despite the recent pullback. Fundamentals — $1.17B Q2 revenue, 90% YoY growth, a $5.15B backlog and FCF of $482M — support a tactical long. Technicals show oversold conditions; valuation is rich but justifiable given growth. Trade plan: enter $462…
Chevron’s $7 billion commitment to expand Venezuelan output to ~600k bpd is the kind of low-cost, high-leverage production growth investors prize. At roughly $211.91 today, CVX screens as a reasonably valued major with a 3.3% yield, strong free cash flow of $27.0B, and conservative leverage. This trade idea buys into that upside with disciplined ri…
High Tide's Q2 beat, the Bank of Montreal C$40M facility, and recent German/M&A activity create a clear, tradable upside path. At a market cap of ~$222M and implied revenue multiple below 0.5x on an annualized basis, the stock offers asymmetric upside if execution in Germany and domestic roll-ups continue. This trade idea lays out entry, stop, targ…
LyondellBasell (LYB) looks like a high-conviction swing trade. The stock is trading near $66.59 while the business is generating meaningful free cash flow and sits at an attractive EV/EBITDA multiple. We lay out an entry at $66.59, a stop at $60.00 and a target of $77.00, driven by improving polymer markets, durable FCF and a recovering EBITDA prof…
AMD is positioned to take a larger share of the AI compute market thanks to competitive server CPUs and accelerating GPU/accelerator momentum. This trade plan lays out an entry at $140.00 with a $190.00 target and a $120.00 stop, sized for a medium-risk, long-term horizon of 180 trading days.
Atlanta Braves Holdings (BATRA) offers a mix of operating cash flow from a top-tier MLB franchise and sizable real-estate optionality at The Battery Atlanta. Recent industry transactions (including the high-profile Angels sale) are fresh evidence buyers will pay for sports franchises and adjacent commercial assets, and that could re-rate BATRA's $3…
GrafTech (EAF) is a cyclical, capital-intensive producer of graphite electrodes and needle coke. The stock trades at a sub-$200M market cap while enterprise value sits above $1.2B, reflecting a capital structure and cash flow profile that keeps the equity volatile. Recent industry reports point to strengthening needle coke demand and a multi-year s…
